{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:54:02Z","timestamp":1790729642978,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1097\/inf.0000000000000451","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T04:13:15Z","timestamp":1405570395000},"page":"1216-1221","source":"Crossref","is-referenced-by-count":56,"title":["Trends of Pneumococcal Meningitis in Children After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in France"],"prefix":"10.1097","volume":"33","author":[{"given":"Corinne","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"B\u00e9chet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Martinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bonacorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1016\/j.vaccine.2012.08.012","article-title":"Israeli Bacteremia and Meningitis Active Surveillance Group. Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel.","volume":"30","author":"Ben-Shimol","year":"2012","journal-title":"Vaccine"},{"key":"R2-2-20210202","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/INF.0b013e318124a494","article-title":"Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.","volume":"26","author":"Black","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R3-2-20210202","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1016\/j.vaccine.2013.10.032","article-title":"Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.","volume":"31","author":"Steens","year":"2013","journal-title":"Vaccine"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial meningitis in the United States, 1998-2007.","volume":"364","author":"Thigpen","year":"2011","journal-title":"N Engl J Med"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12325-013-0051-2","article-title":"A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis.","volume":"30","author":"Tin Tin Htar","year":"2013","journal-title":"Adv Ther"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1086\/587897","article-title":"Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States.","volume":"46","author":"Tsai","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype Replacement Study Group. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/INF.0b013e3181f4cf69","article-title":"Bacterial Meningitis Study Group. Pneumococcal meningitis in French children before and after the introduction of pneumococcal conjugate vaccine.","volume":"30","author":"Levy","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R9-2-20210202","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3201\/eid1609.100102","article-title":"Pneumococcal serotypes in children in 4 European countries.","volume":"16","author":"Hanquet","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.medmal.2009.03.006","article-title":"Epidemiology of pediatric bacterial meningitis in France.","volume":"39","author":"Levy","year":"2009","journal-title":"Med Mal Infect"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.inf.0000157090.40719.9b","article-title":"Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.","volume":"24","author":"Haddy","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"320309","DOI":"10.1155\/2012\/320309","article-title":"Diagnosis and management of bacterial meningitis in the paediatric population: a review.","volume":"2012","author":"Tacon","year":"2012","journal-title":"Emerg Med Int"},{"key":"R17-2-20210202","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.arcped.2013.05.016","article-title":"Annual trends (2008-2011) in early childhood vaccination coverage for the French population: the Vaccinoscopie() study.","volume":"20","author":"Martinot","year":"2013","journal-title":"Arch Pediatr"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1086\/432944","article-title":"Bacterial Meningitis Study Group. Bacterial meningitis in children: a French prospective study.","volume":"41","author":"Bingen","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10096-007-0417-y","article-title":"Bacterial Meningitis Study Group. Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation.","volume":"27","author":"Bingen","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","article-title":"Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine.","volume":"29","author":"Miller","year":"2011","journal-title":"Vaccine"},{"key":"R23-2-20210202","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R24-2-20210202","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/acem.12203","article-title":"Rates of emergency department visits due to pneumonia in the United States, July 2006-June 2009.","volume":"20","author":"Self","year":"2013","journal-title":"Acad Emerg Med"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).","volume":"19","author":"Richter","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"R26-2-20210202","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1542\/peds.2013-0621","article-title":"Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah.","volume":"132","author":"Stockmann","year":"2013","journal-title":"Pediatrics"},{"key":"R27-2-20210202","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1542\/peds.2008-1702","article-title":"Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.","volume":"125","author":"Kaplan","year":"2010","journal-title":"Pediatrics"},{"key":"R28-2-20210202","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.inf.0000207484.52850.38","article-title":"U.S. Pediatric Multicenter Pneumococcal Surveillance Group. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine.","volume":"25","author":"Gonzalez","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R31-2-20210202","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3201\/eid1901.120741","article-title":"Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.","volume":"19","author":"Ladhani","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"R32-2-20210202","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.vaccine.2009.02.063","article-title":"Epidemiology of pneumococcal meningitis hospitalizations in pediatric population in Spain (1998-2006).","volume":"27","author":"Gil Prieto","year":"2009","journal-title":"Vaccine"},{"key":"R33-2-20210202","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1128\/AAC.41.9.2050","article-title":"Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.","volume":"41","author":"Doit","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"R35-2-20210202","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis.","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R36-2-20210202","first-page":"S97","article-title":"Observatoire des meningites bacteriennes de lenfant en France. Editorial.","volume":"15","author":"BeCSd","year":"2009","journal-title":"Arch Pediatr"},{"key":"R37-2-20210202","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.arcped.2014.04.025","article-title":"Change in French bacterial meningitis in children resulting from vaccination.","volume":"21","author":"Levy","year":"2014","journal-title":"Arch Pediatr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:04:33Z","timestamp":1620939873000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201412000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000451","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718496831.793527173","asserted-by":"object"}]},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}